Company: CDT
Filing Date: 2025-04-16
Form Type: PRE 14A
Source: 0001641172-25-005096
Chunk: 25

Company: CDT Equity Inc.
Filing Date: 2025-04-16
Form: PRE 14A
Chunk 25
---
 and without the necessity of presenting the same for exchange, represent that number of whole shares of Common Stock after the Reverse Stock Split Effective Time into which the shares formerly represented by such certificate have been reclassified as well the right to receive cash in lieu of fractional shares of Common Stock to which such holder may be entitled; provided, however, that each person of record holding a certificate that represented shares of Common Stock that were issued and outstanding immediately prior to the Reverse Stock Split Effective Time shall receive, upon surrender of such certificate, a new certificate evidencing and representing the number of whole shares of Common Stock after the Reverse Stock Split Effective Time into which the shares of Common Stock formerly represented by such certificate shall have been reclassified as well as the right to receive cash in lieu of fractional shares of Common Stock to which such holder may be entitled.”

| 2. | That                                                                                                                                
 the aforesaid amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General Corporation Law 
 of the State of Delaware.                                                                                                           |

1Shall be a whole number equal to or greater than two (2) and equal to or lesser than one hundred (100) and shall include not more than four decimal digits, which number is referred to as the “Reverse Split Factor” (it being understood that any Reverse Split Factor within such range shall, together with the remaining provisions of this Certificate of Amendment not appearing in brackets, constitute a separate amendment being approved and adopted by the board of directors and stockholders in accordance with Section 242 of the Delaware General Corporation Law).

IN WITNESS WHEREOF, this Certificate of Amendment has been executed by a duly authorized officer of the Corporation on this _____ day of _______, 20____.

| CONDUIT              
 PHARMACEUTICALS INC. |
| By:                  |
| Name:                |
| Title:               |

<div align='center'>[ Signature Page to Certificate of Amendment]</div>

<div align='center'>PRELIMINARY PROXY STATEMENT, SUBJECT TO COMPLETION, DATED APRIL 16, 2025</div>